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Abstract
Lactate is an essential component of carbon metabolism in mammals. Recently, lactate was
shown to signal through the G protein coupled receptor 81 (GPR81) and to thus modulate
inflammatory processes. This study demonstrates that lactate inhibits pro-inflammatory sig-
naling in a GPR81-independent fashion. While lipopolysaccharide (LPS) triggered expres-
sion of IL-6 and IL-12 p40, and CD40 in bone marrow-derived macrophages, lactate was
able to abrogate these responses in a dose dependent manner in Gpr81-/- cells as well as in
wild type cells. Macrophage activation was impaired when glycolysis was blocked by chemi-
cal inhibitors. Remarkably, lactate was found to inhibit LPS-induced glycolysis in wild type
as well as in Gpr81-/- cells. In conclusion, our study suggests that lactate can induce
GPR81-independent metabolic changes that modulate macrophage pro-inflammatory
activation.
Introduction
Low-molecular-weight metabolites such as bacterium-derived short chain fatty acids (SCFAs)
have emerged as important local modulators of immune cell function[1, 2]. Among fermenta-
tion end products, lactate is the only one of these metabolites produced by both (i) lactic acid
bacteria (i.e. Lactobacillus and Lactococcus species) and other intestinal microorganisms during
the fermentation of carbohydrates, and (ii) the host metabolism at homeostasis and during dis-
ease states, such as infection and cancer. Consequently, immune cells migrating to different
body sites may be exposed to variable lactate levels in different microenvironments. The gas-
trointestinal mucosa is exposed transiently to high lactate concentration from fermented food
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in the proximal segments[3]. Thus, the lactobacilli, bifidobacteria and other microbiota mem-
bers can produce10 mM in steady state in the terminal ileon or colon [4, 5]. However, differ-
ences in diet and microbial composition, as well as surgical or pharmacological interventions
may increase the lactate intestinal levels [6]. Concentrations of lactate > 100 mM are found in
microenvironments such as the vagina in which lactic acid bacteria are the most represented
population [7]. Furthermore, in specific conditions, host cells can produce lactate, as exempli-
fied during macrophage M1 activation during infection [8, 9]. Otherwise, proliferating cancer
cells normally acquire a high glycolytic rate metabolism with low oxygen consumption, the so
called “Warburg metabolism” that results in increased lactate concentration in the tumor envi-
ronment [10].
There is evidence that lactic acid or lactate modulate the maturation of monocytes, macro-
phages and other myeloid cells contributing to non-inflammatory phenotypes [11–13]. The
molecular mechanisms responsible for this activity are not clear, being the capacity to activate
specific GPCR or histone deacetylases, possible mediators of such effects [3]. GPR81 (or
HCAR1) is the only GPCR described so far with capacity to bind lactate in physiological con-
centrations [14, 15]. A recent study reported that the exogenous administration of lactate
inhibits the Toll-like receptor 4 (TLR4)-dependent pro-inflammatory responses in murine
and human macrophages stimulated by LPS [16]. Using siRNA, it was suggested that the
inhibitory effect is dependent on GPR81 signaling and it may be active in in vivo pathological
situations like toxic hepatitis and pancreatitis [16].
Taking into account that multiple situations may contribute to changes in lactate concen-
tration in the cellular environment, it is important to elucidate how endogenous or exogenous
lactate influences overall immune responses to characterize disease mechanisms and develop
novel prophylaxis methods. Aiming at further determining the pathways associated with the
modulatory capacity of lactate on innate immune cells, we here described the use of bone mar-
row-derived macrophages (BMM) from GPR81 genetically deficient mice. Our findings indi-
cate that lactate blocks LPS activation of macrophages in a GPR81-independent manner by
modulating cell metabolic activity.
Material & Methods
Reagents
Racemic DL-lactic acid (J. T. Baker, USA) and NaOH 1 mol/L was used to prepare an aqueous
lactate solution at 0.5 mol/L, pH 7.4. Lactate solutions were then filtered through a 0.45 μm
membrane filter and stored at -20˚C. Ultrapure LPS from Escherichia coli serotype 0111:B4
was from InvivoGen (Toulouse, France). All cell culture media, serum, and supplements were
purchased from Gibco1. Glycolysis inhibitors 2-deoxyglucose and 3-bromopyruvate were
purchased from Sigma-Aldrich (Lyon, France)
Animal procedures: Macrophage generation
Female C57BL/6J (6–8 weeks old) mice were obtained from Janvier Laboratories
(St. Berthevin, France). Gpr81-/- and wild type littermates were generated as previously
described [17]. To perform the experiments involving ex vivo cell analysis, animals were eutha-
nasied by cervical dislocation under xilazine/ketamine i.p. anesthesia (French protocol CEEA
052011). Animals were maintained at the animal facility of Institut Pasteur de Lille (agree-
ment#A59-350009). All experiments complied with current national and institutional regula-
tions and ethical guidelines and the procedure was approved by the Institutional Animal Care
and Use Committee (IACUC). Bone marrow (BM) from femurs and tibias was used as a
source of hematopoietic cell precursors to differentiate macrophages (BMM) as previously
GPR81-Independent Inhibition of Macrophage Proinflammatory Activation
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described [18]. Peritoneal macrophages were obtained by flushing the peritoneal cavity with 5
mL of PBS and adhesion for 2h at 37˚C on culture plates. Cells were left untreated or stimu-
lated with (i) 100 ng/mL of LPS, (ii) various concentrations of lactate, (iii) combinations of
LPS and lactate, or (iv) combinations of LPS and glycolysis inhibitors. Cells were processed
after 3h stimulation for gene expression analysis or after 16h stimulation for cytokine secretion
or flow cytometry analysis. Cell numbers and viability were assessed using Trypan blue solu-
tion and CountessTM Automated Cell Counter (Life Technologies) and CellTiter 961AQue-
ous One Solution (Promega) as specified by the manufacturer.
Gene expression analysis
Total RNA from stimulated cells was extracted with the Nucleospin XS kit (Macherey Nagel,
Germany). RNA was reverse-transcribed with the High-Capacity cDNA Archive Kit (Life
Technologies, USA). The resulting cDNA was amplified using SYBR Green-based real-time
PCR and the 7300 Real Time PCR system (Applied Biosystems, USA) following the manufac-
turer´s protocol. The specific primers are CGTCATCCATGGCGAACTG/GCTTCTTTGCAG
CTCCTTCGT (Actb, a house-keeping gene coding for β-actin), AATCTATACCTGTCCTGT
GTAATGAAAGAC/TGGGTATTGCTTGGGATCCA (Il1b), GTTCTCTGGGAAATCGTGG
AAA/AAGTGCATCATCGTTGTTCATACA (Il6), GCAAAGAAACATGGACTTGAAGTT
C/CACATGTCACTGCCCGAGAGT (Il12b), TGCTGGTCATTCCTGTCGT/TTGGTTTCT
TGACCACCTTTTT (Cd40), ATGCTGCCCTGTCCTCCT/CCACAAGCCCAGTACGTGTA
T (Slc16a1-MCT1), ATCGTGGGCACTCAGAAGTT/TTTGGTTGCATCCAGCAG (Slc16a3-
MCT4) and GGCTGAGAAAAGCGGTATGA/TCGTTAACTCTCTCCGAGCTAGA (Gpr81).
Relative mRNA levels (2-ΔΔCt) were determined by comparing (i) the cycle thresholds (Ct) for
the gene of interest and Actb (ΔCt) and (ii) ΔCt values for treated and control groups (ΔΔCt). Ct
upper limit was fixed to 33 cycles.
Determination of cytokine production
IL-6 and IL-12 p40 concentration in cell-free supernatants were measured using ELISA kits
(eBioscience, USA) following the manufacturer’s instructions.
Cellular metabolic analysis
Seahorse XF24 Extracellular Flux Analyzer (Seahorse Biosciences) was used to obtain real-time
measurements of glycolytic flux in macrophage measured by extracellular acidification rate
(ECAR). Briefly, macrophages were seeded in 24-well Seahorse culture plates at a density of
150.000 cells/well. Before analysis of ECAR, growing medium was removed and cells were
incubated in DMEM (Sigma) supplemented with glutamine (Invitrogen) (2mM). ECARs were
analyzed using a cycle of 2 min of mixing followed by 3’ measurement cycle. Oligomycin
(Sigma) and 2-deoxyglucose (Sigma) were injected at a final concentration of 2μM and
100mM respectively. ECARs were normalized to DNA content using Cyquant assay (Invitro-
gen). Data are presented as mean ± SEM.
Statistical analysis
The Mann Whitney test was used for comparison between the two groups. For multiple com-
parisons, analysis of variance using Kruskall-Wallis test was performed. The differences were
considered statistically significant for p< 0.05. All analyses were performed using the Graph
Pad Prism program, version 5.0.
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Results & Discussion
To define the effect of lactate on the pro-inflammatory response of myeloid cells, we used
TLR4-dependent activation by LPS of BMM (Fig 1). As expected, LPS stimulation increased
transcription of Il1b, Il6, Il12b, and Cd40 genes (Fig 1A–1D) and the secretion of IL-6, IL-12
p40 and IL-1b (Fig 1E–1G). In contrast, we observed that lactate inhibited the secretion and
the transcription of these pro-inflammatory mediators in a dose-dependent manner. The
experiments showed almost complete abrogation of activation at lactate concentration higher
than 50 mM for most of the markers analyzed. In all conditions, using trypan blue and tetrazo-
lium salt reduction, cell numbers were mostly unaffected and viability was shown >75%
related to control cells (S1 Fig). A similar behavior was observed for peritoneal macrophages.
Indeed, peritoneal macrophages showed high expression of pro-inflammatory markers il1b,
Il6, Il12b, Nlrp3 and Cd40 upon LPS activation that was impaired by increasing concentrations
of lactate (Fig 2A–2E). Il12b expression was found to be down-regulated at concentration of
Fig 1. Lactate inhibits the LPS-mediated activation of bone marrow-derived macrophages. BMMs from C57BL/6 mice were incubated with
various lactate concentrations in the presence or absence of LPS (100 ng/ml). (A-D) Messenger RNA levels were measured 3h post-stimulation and
were expressed relative to those in mock cells that were not exposed to LPS or lactate (arbitrarily set to a value of 1). (E-G) Cytokine secretion by
BMMs after 16h stimulation was measured by ELISA.The results are representative of four experiments and are expressed as the mean ± SEM.
Statistically significant differences vs. LPS-treated cells are indicated as * p<0.05, ** p<0.01 and *** p<0.005.
doi:10.1371/journal.pone.0163694.g001
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10 mM lactate, whereas almost all other pro-inflammatory genes were no more expressed
upon treatment with 50 mM lactate. As was observed for BMM, secretion of IL-6 induced by
LPS was modulated by concentrations of lactate higher than 50 mM (Fig 2F). The present
work thus corroborates the observations of Hoque et al. on the effect of lactate on wild type
macrophages [16]. Importantly, treatment with lactate by itself did not alter the basal expres-
sion or secretion of the pro-inflammatory factors (data not shown). Lactate tissue levels may
vary from 1 mM to 10 mM depending on tissue and metabolic state [19], and in pathological
situation such as cancer these levels may be increased 2-to-5-fold [20–23]. Furthermore, some
bacterial infections [8] may also rise tissue lactate levels from 10 to 30 mM. Consequently, our
results indicate that pathophysiological levels of lactate, as reached in vivo, may have an impact
on macrophage activation phenotype, as was also previously shown [10].
GPR81, which is produced on adipocytes, was recently identified as the main lactate sensor
in the regulation of fatty acid metabolism [14]. We further assessed GPR81’s contribution to
lactate-mediated immunosuppression by studying cells derived from GPR81-deficient mice
(Gpr81-/-) [17]. In contrast to Hoque et al. [16], we found that in murine Gpr81-/- BMMs tran-
scription of the pro-inflammatory genes Il1b, Il6, Il12b, and Cd40 was down-modulated by lac-
tate treatment (Fig 3A–3D). Furthermore,. these cells responded to lactate by downregulating
the LPS-mediated IL-6 and IL-12 p40 secretion, following a dose response similar to that
observed for GPR81-proficient cells (Fig 3E and 3F). As previously shown [14], Gpr81 was
highly expressed in visceral or subcutaneous fat tissue but the expression was 100-fold lower in
secondary lymphoid organs or gut tissues (S2A Fig). Furthermore, Gpr81m RNA levels in
BMMs were >1000-fold lower than those in adipose tissue (S2B Fig). Taken together, these
data indicate that lactate can induce modulation of the pro-inflammatory response via a
Fig 2. Lactate inhibits LPS-mediated activation of peritoneal macrophages. Peritoneal macrophages from C57BL/6 mice were incubated with
various lactate concentrations in the presence or absence of LPS (100 ng/ml). (A-E) Gene expression was determined upon 3h of treatment. Messenger
RNA levels were expressed relative to those in mock cells that were not exposed to LPS or lactate (arbitrarily set to a value of 1). (F) Il-6 secretion by
peritoneal macrophages after 16h stimulation was measured by ELISA. The results are representative of two experiments and are expressed as the
mean ± SEM. Statistically significant differences vs. LPS-treated cells are indicated as * p<0.05, ** p<0.01 and *** p<0.005.
doi:10.1371/journal.pone.0163694.g002
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GPR81-independent signaling pathway. Interestingly, we observed that peritoneal macro-
phages also used in the Hoque et al.’s study, displayed higher levels of Gpr81 expression than
BMMs (S2B Fig). However, activation of GPR81-deficient peritoneal macrophages was also
inhibited by increasing concentrations of lactate (S3 Fig). These data suggest that (1) Gpr81
expression and GPR81 activity may be environmentally controlled in macrophages, and (2)
macrophages can respond to lactate in specific conditions in a GPR81-independent manner.
Glycolysis is essential for the production of pro-inflammatory response by macrophages
and dendritic cells [13] and extensive metabolic changes usually occur upon macrophage acti-
vation. Particularly, pro-inflammatory signals promote a rise in the glycolysis rate, inhibition
of oxygen consumption, and increased mitochondria use of aspartate-argininosuccinate shunt
to replenish the oxaloacetate pool [24, 25]. These changes facilitate generation of NO and lipid
mediators of inflammation such as specific eicosanoids [24, 26]. It has been shown that pertur-
bation of this metabolic remodeling by glycolysis inhibition abrogates IL6 production by mac-
rophages upon LPS stimulation [26]. In agreement with these results, we observed that
inhibitors of glycolysis abrogate LPS-induced production of pro-inflammatory mediators in
BMM to similar extent of lactate (Fig 4). Both 2-deoxyglucose and 3-bromopyruvate inhibited
the first steps of glycolysis (S4 Fig). Using these inhibitors we observed a decrease in the pro-
duction of IL-6 and IL-12p40 in a dose dependent manner. Furthermore, the effects of the
inhibitor were reinforced in the presence of lactate 75 mM, showing an additive effect (Fig 4).
These results suggest that lactate may contribute to modulation of glycolysis activity upon LPS
activation. In order to further determine the impact of lactate on macrophage metabolism, we
measured the extracellular acidification rate (ECAR, a surrogate marker of glycolytic activity).
Fig 3. Lactate’s modulatory effects on LPS-stimulated BMMs are independent of GPR81. BMMs were derived from the bone marrow of
Gpr81-/-and wild-type mice (littermate). The cells were incubated with various lactate concentrations in the presence or absence of LPS (100 ng/ml).
(A-D) Gene expression was determined upon 3h of treatment. Messenger RNA levels were expressed relative to those in mock cells that were not
exposed to LPS or lactate (arbitrarily set to a value of 1). (E-F) Cytokine secretion in Gpr81-/- BMMs after 16h stimulation was measured by ELISA. The
results are representative of two to four experiments and are expressed as the mean ± SEM. Statistically significant differences vs. LPS-treated cells are
indicated as * p<0.05, ** p<0.01 and *** p<0.005.
doi:10.1371/journal.pone.0163694.g003
GPR81-Independent Inhibition of Macrophage Proinflammatory Activation
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As previously reported [27], LPS stimulated the ECAR, whereas lactate was found to fully
abrogate the LPS-mediated induction of glycolysis (Fig 5A). Interestingly, Gpr81-/-and wild-
type BMMs responded similarly to lactate and LPS (Fig 5B); in both cases, treatment with lac-
tate fully abrogated the rise in the glycolysis rate upon LPS stimulation. In both cell genotypes,
the treatment with lactate in the absence of LPS also resulted in a lower rate of glycolysis. The
monocarboxylate transporters MCT4 and MCT1 could be the major transporters responsible
Fig 5. Extracellular lactate abrogates LPS-induced macrophage glycolysis in a GPR81-independent
manner. The extracellular acidification rate (ECAR) was measured as a surrogate marker of glycolysis using
a SeaHorse Extracellular Flux analyzer. The cells were initially stimulated with LPS (100 ng/ml) and/or lactate
(68 mM), and water alone was used as an additive for a non-stimulated control condition. In all the
experiments, sequential treatment with oligomycin (oli) and then 2-deoxyglucose (2DG) was used to inhibit
the mitochondrial respiratory chain and block glycolysis, respectively. Similar experiments were performed
with C57BL/6 (A) and Gpr81-/- BMMs (B). The results are representative of three experiments and are
expressed as the mean ± SEM.
doi:10.1371/journal.pone.0163694.g005
Fig 4. Inhibition of glycolysis impairs expression of pro-inflammatory mediators by macrophages. BMMs from C57BL/6 mice were incubated
for 16h with 75 mM lactate±LPS (100 ng/ml) ± glycolysis inhibitors (2-deoxyglucose: 2DG; 3-Bromopyruvate: Br-PA) at indicated concentrations.
Cytokine secretion by BMMs was measured by ELISA for IL-12 p40 (A) and IL-6 (B). The results are representative of two experiments and are
expressed as the mean ± SEM. Statistically significant differences vs. LPS-treated cells are indicated as * p<0.05, ** p<0.01 and *** p<0.005;
whereas differences vs. LPS+lactate treated cells are indicated as ˚ p<0.05, ˚˚ p<0.01 and ˚˚˚ p<0.005.
doi:10.1371/journal.pone.0163694.g004
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for lactate secretion or influx, respectively [28]. It was recently shown that the lactate mem-
brane transporter MCT4 is induced in macrophages upon TLR activation, being critical for
the transport of lactate produced upon cell activation [27]. Blockade of the macrophages’
capacity to export lactate [27] or high concentrations of lactate in the extracellular milieu [29]
have been shown to dramatically decrease the glycolysis rate, even upon LPS activation. We
evaluated MCT4 and MCT1 expression in macrophages used for our experiments (S5 Fig). In
all cases, both genes were expressed resulting in Cts for amplification around 25 cycles (not
shown), indicating intermediate levels of expression. BMM showed increased expression of
MCT1 and MCT4 upon lactate incubation, whereas basal levels were not significantly changed
in lactate-treated peritoneal macrophages. These results indicate that lactate can be traslocated
from outside or inside following gradient concentrations in the conditions used in our experi-
ments. Consequently, a raise in extracellular lactate can be mirrored by a raise in intracellular
lactate facilitated by MCT action, and this may then influence in other cellular activities such
as glycolisis, as previously described [30]. A correlation between the blockade of glycolysis
activity and the lack of macrophage pro-inflammatory activation upon LPS stimulation was
observed [27, 29]. Interestingly, it was recently shown by in vitro and in vivo approaches that
impaired glycolytic activity is a hallmark of the “immunoparalysis” phenotype observed in cir-
culating leukocytes upon severe sepsis corresponding to a state of low cytokine production
upon proinflammatory stimulation [31]. The GPR81-independent modulatory effects on pro-
inflammatory activation described herein may also be associated to such modulation of meta-
bolic pathways in myeloid cells.
There is an increasingly large body of evidence showing that lactate can modulate immune
cell function [5, 10, 32]. Local lactate concentrations in different tissues can reach the values
that were modulatory in our model system [5, 32]. Thus lactate can have functional conse-
quences as shown in tumor models [10]. It is known that tumor progression is correlated with
the production of lactate [33], pointing to the importance of immunopathological mechanisms
triggered by this metabolite. Lactate’s modulatory effects on cell types that are critical players
in the orchestration of the immune response may contribute significantly to this observation.
Results shown here contribute to the elucidation of the mechanisms responsible for lactate bio-
activity, which might facilitate the development of new therapeutic strategies for critical health
problems such as inflammatory bowel disease and cancer.
Supporting Information
S1 Fig. High concentrations of lactate do not significantly impair macrophage viability.
Bone marrow-derived macrophages (BMM, A and C) or peritoneal macrophages (PM, B and
D) from C57BL/6 mice were incubated for 16h with various lactate concentrations in the pres-
ence or absence of LPS (100 ng/ml). (A-B) Viable cell numbers were measured using trypan
blue staining and an automated cell counter CountessTM. (C-D) Macrophage viability was also
assessed using a tetrazolium salt reduction assay and measurement of absorbance at 490 nm
(CellTiter 961 AQueous One Solution). Total absence of viability was associated with an
absorbance at 490 nm of 0.164 ± 0.006. The results are representative of two experiments and
are expressed as the mean ± SEM. Statistically significant differences vs. LPS-treated cells are
indicated as  p<0.05,  p<0.01 and  p<0.005.
(TIF)
S2 Fig. Gpr81 transcript levels are very low in macrophages. Gpr81 mRNA levels were
assessed by real time quantitative RT-PCR in (A) different tissues from C57BL/6 mice, and in
(B) peritoneal macrophages (PM) and bone marrow-derived macrophages (BMM) from
C57BL/6 mice. Messenger RNA levels are expressed relative to those in visceral fat tissue
GPR81-Independent Inhibition of Macrophage Proinflammatory Activation
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(arbitrarily set to a value of 1). The results are representative of two experiments and are
expressed as the mean ± SEM. Statistically significant differences vs. visceral fat are indicated
as  p<0.05,  p<0.01 and  p<0.005.
(TIF)
S3 Fig. Lactate inhibits LPS-mediated activation of Gpr81-/- peritoneal macrophages. Peri-
toneal macrophages from C57BL/6 and Gpr81-/- mice were incubated for 16h with various lac-
tate concentrations in the presence or absence of LPS (100 ng/ml). Cytokine secretion was
measured by ELISA. The results are representative of two experiments and are expressed as
the mean ± SEM. Statistically significant differences vs. LPS-treated cells are indicated as 
p<0.05,  p<0.01 and  p<0.005.
(TIF)
S4 Fig. Molecular targets of different metabolic inhibitors. Schematic representation of cen-
tral carbon metabolism. The steps that are inhibited by the different compounds used in Fig 4
are indicated.
(TIF)
S5 Fig. Lactate transportesrs MCT1 and MCT4 are expressed in macrophages. MCT1
(Slc16a1) and MCT4 (Slc16a4)mRNA levels were assessed by real time quantitative RT-PCR
in BMMs (A-B) and peritoneal macrophages (C-D) used for our studies. Messenger RNA lev-
els in treated cells are expressed relative to those in untreated (arbitrarily set to a value of 1).
The results are representative of two experiments and are expressed as the mean ± SEM.
(TIF)
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